Search research articles
Contact Us
Filters
Showing results (31-40 of 254) with videos related to
Page
of 26
Sort By:
Leukemia Research
|
January 11, 2007
A therapy resistant myelodysplastic syndrome characterized by the presence of the rare reciprocal translocation t(3;12)(q26.2;p13)
Enrico Orciuolo, Gabriele Buda, Nadia Cecconi, et al.
Journal of Leukocyte Biology
|
September 24, 2008
Lithium and hematology: established and proposed uses
Daniele Focosi, Antonio Azzarà, Richard Eric Kast, et al.
Journal of Visualized Experiments : Jove
|
August 9, 2016
Isolating Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow
Marina Montali, Serena Barachini, Simone Pacini, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
July 27, 2016
ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview
Elena Arrigoni, Sara Galimberti, Mario Petrini, et al.
Journal of the National Cancer Institute
|
August 19, 2009
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials
Marco Tuccori, Daniele Focosi, Corrado Blandizzi, et al.
Blood Research
|
May 8, 2020
Large granular lymphocytes (LGL) in primary Sjögren syndrome (pSS): immunophenotype and review on the pathological role of T cells in pSS
Rita Tavarozzi, Giovanni Carulli, Enrica Manzato, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 26, 2016
How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases
Giulia Cervetti, Francesco Ghio, Nadia Cecconi, et al.
Leukemia Research
|
January 15, 2008
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo study
Sara Galimberti, Martina Canestaro, Eugenio Ciancia, et al.
Hematological Oncology
|
April 3, 2008
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma
Daniele Focosi, Nadia Cecconi, Giuseppe Boni, et al.
Leukemia Research
|
April 25, 2008
JAK-2V617F mutation in RARS-t: a target for Imatinib therapy?
Elisa Cannizzo, Giovanni Carulli, Antonio Azzarà, et al.
Page
of 26
Search research articles
Search
Showing results (31-40 of 254) with videos related to
Sort By:
Page
of 26
Leukemia Research
|
January 11, 2007
A therapy resistant myelodysplastic syndrome characterized by the presence of the rare reciprocal translocation t(3;12)(q26.2;p13)
Enrico Orciuolo, Gabriele Buda, Nadia Cecconi, et al.
Journal of Leukocyte Biology
|
September 24, 2008
Lithium and hematology: established and proposed uses
Daniele Focosi, Antonio Azzarà, Richard Eric Kast, et al.
Journal of Visualized Experiments : Jove
|
August 9, 2016
Isolating Mesangiogenic Progenitor Cells (MPCs) from Human Bone Marrow
Marina Montali, Serena Barachini, Simone Pacini, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
July 27, 2016
ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview
Elena Arrigoni, Sara Galimberti, Mario Petrini, et al.
Journal of the National Cancer Institute
|
August 19, 2009
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials
Marco Tuccori, Daniele Focosi, Corrado Blandizzi, et al.
Blood Research
|
May 8, 2020
Large granular lymphocytes (LGL) in primary Sjögren syndrome (pSS): immunophenotype and review on the pathological role of T cells in pSS
Rita Tavarozzi, Giovanni Carulli, Enrica Manzato, et al.
Journal of Chemotherapy (Florence, Italy)
|
July 26, 2016
How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases
Giulia Cervetti, Francesco Ghio, Nadia Cecconi, et al.
Leukemia Research
|
January 15, 2008
Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo study
Sara Galimberti, Martina Canestaro, Eugenio Ciancia, et al.
Hematological Oncology
|
April 3, 2008
Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma
Daniele Focosi, Nadia Cecconi, Giuseppe Boni, et al.
Leukemia Research
|
April 25, 2008
JAK-2V617F mutation in RARS-t: a target for Imatinib therapy?
Elisa Cannizzo, Giovanni Carulli, Antonio Azzarà, et al.
Page
of 26